STINGRAY BIO LIMITED
Significant control: Georgios Giamas (25–50%), O2h Ventures Limited (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Stingray Bio Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Stingray Bio Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
STINGRAY BIO LIMITED is an active private limited company (company number 13065548) incorporated on 6 December 2020, registered in Cambridge. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 31 December 2025, showing net assets of £16k, with 0 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 7% on the prior period (£17k). Across the last 3 periods on record the net-asset trend is falling.
By net assets it sits in the upper half of 196 comparable companies in Cambridge (median £15k, upper quartile £347k).
Ownership and control
- Mr Georgios Giamas
- owns 25–50% of shares
- holds 25–50% of voting rights
- O2h Ventures Limited
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 6 December 20205 yrs ago
- Next accounts due
- 30 September 2027in 339 days
- Confirmation statement due
- 20 December 2026in 55 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2025 | £16k | — | — | £331 | — | — | 0 |
| 31 December 2024 | £17k | — | — | £660 | — | — | 0 |
| 31 December 2023 | £21k | — | — | £26k | — | — | 0 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Filing and accounts signals
- Net assets above zeroNet assets £15,867 at 31 December 2025
- Current assets at least 1.5× creditors within one yearCurrent ratio 51.93
- Three or more accounting periods on record3 periods on record
- Incorporated five or more years agoIncorporated 6 December 2020
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Next accounts duein 339 days
- Confirmation statement duein 55 days
- Accounts period endNet assets £16k · micro accounts
- Accounts period endNet assets £17k · micro accounts
- Accounts period endNet assets £21k · micro accounts
- Incorporated
Similar companies in Cambridge
- VIROLOGICA LIMITEDCambridge · inc. Dec 2020
- 4BASEBIO DISCOVERY LIMITEDCambridge · inc. Oct 2020
- CAMBRIDGE NUCLEOMICS LTDCambridge · inc. Jan 2021
- NEOBE THERAPEUTICS LTDCambridge · inc. Jan 2021
- GOLDMAB LIMITEDCambridge · inc. Oct 2020
- VIVAVACS LIMITEDCambridge · inc. Feb 2021
All companies incorporated on 6 December 2020 · in Dec 2020.
Reminders for STINGRAY BIO LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.